Literature DB >> 17318973

Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.

S Erdamar1, P Bagci, B Oz, A Dirican.   

Abstract

PURPOSE: Many characteristics of malignant brain tumors (increased vascular permeability, vasodilatation, neovascularisation and free radical injury to the tumor and adjacent normal tissues) are believed to be mediated by nitric oxide (NO) synthetized by endothelial NO synthase (eNOS). Overexpression of vascular endothelial growth factor (VEGF) is associated with several central nervous system (CNS) diseases and tumors. Our aim was to study immunohistochemically the coexpression of eNOS and VEGF in astrocytic tumors and to analyse their possible correlation with tumor grade, angiogenesis and proliferation index.
MATERIALS AND METHODS: Sections from 120 randomly selected patients with supratentorial astrocytic tumors [38 glioblastomas (GB), 22 anaplastic astrocytomas (AA) and 20 low-grade astrocytomas (LA)], also including oligodendrogliomas (n=20) and mixed oligoastrocytomas (n=20), were immunostained with monoclonal antibodies for eNOS and VEGF using the avidin-biotin method. The proliferative potential was assessed as the MIB-1 staining index for tumor cells.
RESULTS: There was positive correlation between eNOS and VEGF expressions and histological grade (p<0.05) in terms of intensity and extent of immunoreactivity distribution. Oligodendrogliomas showed significantly less VEGF and eNOS immunoreactivity compared to pure astrocytomas (p<0.05).
CONCLUSION: Overexpressions of eNOS and VEGF in astrocytic tumors were significantly correlated with histological grade, proliferative potential and malignant transformation. The expression of VEGF in a necrotic and ischemic tumor such as GB is more intense and diffuse than low-grade astrocytomas. These findings suggest that eNOS overexpression in tumor vasculature would be precipitated by transformation into an angiogenic phenotype in the process of neovascularisation in astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17318973

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  7 in total

Review 1.  NOS Expression and NO Function in Glioma and Implications for Patient Therapies.

Authors:  Anh N Tran; Nathaniel H Boyd; Kiera Walker; Anita B Hjelmeland
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 2.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.

Authors:  Subapriya Rajamanickam; Balaiya Velmurugan; Manjinder Kaur; Rana P Singh; Rajesh Agarwal
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

4.  Prognostic significance of kappaB-Ras1 expression in gliomas.

Authors:  Hong Lin; Yangang Wang; Xiang Zhang; Bolin Liu; Wei Zhang; Jinxiang Cheng
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

5.  Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide.

Authors:  Nicholas A Pullen; Helen L Fillmore
Journal:  J Neurooncol       Date:  2009-07-21       Impact factor: 4.130

6.  Vascular Endothelial Growth Factor as an Angiogenic Marker in Malignant Astrocytoma and Oligodendroglioma: An Indian Scenario.

Authors:  Ramya S Vokuda; Bheemanathi Hanuman Srinivas; Venkatesh S Madhugiri; Surendra Kumar Verma
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 7.  Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies.

Authors:  Maria Peleli; Aristidis Moustakas; Andreas Papapetropoulos
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.